State Street Corp Raises Stock Position in Helmerich & Payne, Inc. (NYSE:HP)

Share on StockTwits

State Street Corp lifted its holdings in shares of Helmerich & Payne, Inc. (NYSE:HP) by 2.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,305,496 shares of the oil and gas company’s stock after purchasing an additional 143,450 shares during the quarter. State Street Corp owned about 0.06% of Helmerich & Payne worth $252,661,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also modified their holdings of the company. FMR LLC increased its stake in Helmerich & Payne by 30.7% during the 1st quarter. FMR LLC now owns 308,156 shares of the oil and gas company’s stock worth $17,121,000 after buying an additional 72,343 shares during the period. Amundi Pioneer Asset Management Inc. boosted its position in Helmerich & Payne by 9.8% in the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 92,738 shares of the oil and gas company’s stock valued at $5,153,000 after buying an additional 8,308 shares during the period. Oregon Public Employees Retirement Fund boosted its position in Helmerich & Payne by 3.6% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 11,635 shares of the oil and gas company’s stock valued at $589,000 after buying an additional 402 shares during the period. State of Alaska Department of Revenue boosted its position in Helmerich & Payne by 7.9% in the 2nd quarter. State of Alaska Department of Revenue now owns 27,506 shares of the oil and gas company’s stock valued at $1,392,000 after buying an additional 2,024 shares during the period. Finally, Commerzbank Aktiengesellschaft FI grew its stake in shares of Helmerich & Payne by 11.9% in the second quarter. Commerzbank Aktiengesellschaft FI now owns 11,314 shares of the oil and gas company’s stock worth $573,000 after acquiring an additional 1,205 shares in the last quarter. 90.50% of the stock is currently owned by institutional investors and hedge funds.

A number of analysts have recently weighed in on the company. Evercore ISI raised Helmerich & Payne from an “in-line” rating to an “outperform” rating and set a $24.00 price objective on the stock in a research report on Monday, November 11th. Deutsche Bank began coverage on Helmerich & Payne in a report on Wednesday, November 27th. They issued a “sell” rating and a $34.00 target price for the company. Zacks Investment Research cut Helmerich & Payne from a “hold” rating to a “sell” rating and set a $40.00 target price for the company. in a research note on Tuesday, October 15th. JPMorgan Chase & Co. lowered their target price on Helmerich & Payne from $64.00 to $54.00 and set an “overweight” rating for the company in a research note on Tuesday, August 6th. Finally, Capital One Financial restated an “overweight” rating on shares of Helmerich & Payne in a report on Tuesday, October 8th. Five research analysts have rated the stock with a sell rating, nine have issued a hold rating and nine have issued a buy rating to the company’s stock. Helmerich & Payne has a consensus rating of “Hold” and a consensus target price of $49.81.

In other Helmerich & Payne news, VP John R. Bell sold 9,000 shares of the firm’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $38.67, for a total transaction of $348,030.00. Following the transaction, the vice president now owns 81,426 shares of the company’s stock, valued at $3,148,743.42. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO John W. Lindsay sold 45,000 shares of Helmerich & Payne stock in a transaction dated Wednesday, November 20th. The stock was sold at an average price of $38.61, for a total value of $1,737,450.00. Following the sale, the chief executive officer now owns 318,441 shares in the company, valued at approximately $12,295,007.01. The disclosure for this sale can be found here. 4.17% of the stock is currently owned by insiders.

HP opened at $38.39 on Wednesday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.35 and a current ratio of 2.72. Helmerich & Payne, Inc. has a one year low of $35.74 and a one year high of $64.80. The company has a market cap of $4.16 billion, a P/E ratio of 21.94, a PEG ratio of 5.00 and a beta of 1.65. The business’s 50-day simple moving average is $39.36 and its 200-day simple moving average is $44.10.

Helmerich & Payne (NYSE:HP) last posted its earnings results on Thursday, November 14th. The oil and gas company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.14. The firm had revenue of $649.10 million during the quarter, compared to analysts’ expectations of $650.92 million. Helmerich & Payne had a positive return on equity of 4.68% and a negative net margin of 1.20%. The firm’s revenue was down 6.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.19 earnings per share. As a group, analysts predict that Helmerich & Payne, Inc. will post 0.49 earnings per share for the current fiscal year.

The business also recently disclosed a — dividend, which was paid on Monday, December 2nd. Shareholders of record on Monday, November 11th were issued a dividend of $0.71 per share. The ex-dividend date was Thursday, November 7th. This represents a yield of 7.4%. Helmerich & Payne’s payout ratio is currently 162.29%.

About Helmerich & Payne

Founded in 1920, Helmerich & Payne, Inc (H&P) (NYSE: HP) is committed to delivering industry leading levels of drilling productivity and reliability. H&P operates with the highest level of integrity, safety and innovation to deliver superior results for its customers and returns for shareholders.

See Also: Buy Rating

Want to see what other hedge funds are holding HP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Helmerich & Payne, Inc. (NYSE:HP).

Institutional Ownership by Quarter for Helmerich & Payne (NYSE:HP)

Receive News & Ratings for Helmerich & Payne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helmerich & Payne and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.